| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.05 |